Mirati Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2018 to Q3 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Mirati Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2018 to Q3 2023.
  • Mirati Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2023 was -2K %, a 68.3% increase year-over-year.
  • Mirati Therapeutics, Inc. annual Operating Margin for 2022 was -6.11K %, a 668% decline from 2021.
  • Mirati Therapeutics, Inc. annual Operating Margin for 2021 was -795 %, a 71.2% increase from 2020.
  • Mirati Therapeutics, Inc. annual Operating Margin for 2020 was -2.76K %, a 58.6% increase from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -2K +4.31K +68.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -2.86K -2.05K -251% Apr 1, 2023 Jun 30, 2023
Q1 2023 -4.07K -3.21K -374% Jan 1, 2023 Mar 31, 2023
Q4 2022 -6.11K -5.31K -668% Oct 1, 2022 Dec 31, 2022
Q3 2022 -6.31K -5.66K -862% Jul 1, 2022 Sep 30, 2022
Q2 2022 -816 +2.93K +78.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -858 +2.28K +72.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -795 +1.96K +71.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -656 +2.11K +76.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -3.74K +13.4K +78.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -3.14K +8.26K +72.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.76K +3.9K +58.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -2.76K +62 +2.19% Jul 1, 2020 Sep 30, 2020
Q2 2020 -17.2K -14.4K -509% Apr 1, 2020 Jun 30, 2020
Q1 2020 -11.4K -8.64K -312% Jan 1, 2020 Mar 31, 2020
Q4 2019 -6.66K -5.87K -739% Oct 1, 2019 Dec 31, 2019
Q3 2019 -2.83K Jul 1, 2019 Sep 30, 2019
Q2 2019 -2.82K Apr 1, 2019 Jun 30, 2019
Q1 2019 -2.77K Jan 1, 2019 Mar 31, 2019
Q4 2018 -794 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.